A carregar...

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma

Fifteen patients with relapsed osteosarcoma were treated with an intensive combination chemotherapy schedule. Ifosfamide 2.5 g m(−2) daily and etoposide 150 mg m(−2) daily coincidentally for 3 days and high-dose methotrexate 8 g m(−2) (with folinic acid rescue) on days 10–14 in a planned 21-day cycl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Michelagnoli, M P, Lewis, I J, Gattamaneni, H R, Bailey, C C, Lashford, L S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 1999
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362262/
https://ncbi.nlm.nih.gov/pubmed/10098754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690187
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!